Post Doc Fellow
The University of Tennesse Heath Sciences
Dr. Amarinder Singh is a dedicated scientist with a strong foundation in pharmacokinetics (PK) and drug metabolism, currently expanding his expertise in population pharmacokinetics (Pop PK), physiologically-based pharmacokinetics (PBPK), and PK/PD analysis. As a Post-Doctoral Fellow at the University of Tennessee Health Science Center, he is honing his skills in pharmacometrics to enhance drug development strategies and clinical pharmacology.
Dr. Singh holds a PhD in Pharmaceutical Sciences and has substantial experience in PK/PD modeling, using tools like Monolix, NONMEM, and R. His research involves the application of Pop PK modeling to understand variability in drug exposure and response across patient populations, aiming to improve dosing strategies and therapeutic outcomes. His work spans the design, execution, and analysis of clinical and preclinical studies, particularly in the context of anti-tuberculosis and oncology drugs.
With over 21 research papers published and a patent to his name, Dr. Singh’s contributions are widely recognized. He is a reviewer for Springer Nature and MDPI journals and serves on the editorial board of PLoS ONE Journal. His academic rigor and leadership are reflected in his mentorship and collaborative approach within multidisciplinary research teams.
Beyond his technical expertise, Dr. Singh is passionate about advancing early drug discovery and development. He strives to ensure that pharmacometric models provide valuable insights into clinical trials and therapeutic strategies. By bridging the gap between pharmacokinetics and clinical pharmacology, Dr. Singh continues to contribute to the optimization of drug therapies for better patient outcomes.